FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to novel derivatives of azethidine and pyrrolidine of the general formula: where A means optionally unsaturated 5- or 6-membered ring that can comprise heteroatom taken among N and S and can be substituted with oxo- or (1-6C)-alkyl; R1,R2,R3 mean independently each of other H, (1-6C)-alkyl, (1-6C)-alkoxy- group, (1-6C)-alkoxy-(1-6C)-alkyl, halogen atom; X means O or S atom; n = 1 or 2; or its pharmaceutically acceptable salt but with exception of 3-(naphtha-1-yl-oxy)-pyrrolidine and 3-(5,6,7,8-tetrahydro-naphth-1-yl- oxy)-pyrrolidine. Compounds of the formula (I) exhibit affinity to receptor 5-HT2c that allows to use their in pharmaceutical composition for treatment or prophylaxis of serotonin-dependent disorders. EFFECT: valuable medicinal properties of compounds. 7 cl, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED BENZYLAMINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF FOR DEPRESSION HEALING | 1997 |
|
RU2179553C2 |
SUBSTITUTED PIPERIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2198172C2 |
INHIBITORS OF SERINE PROTEASES | 1998 |
|
RU2183642C2 |
SERINE PROTEASE INHIBITORS | 1997 |
|
RU2172321C2 |
SERINE PROTEASE INHIBITOR AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2232760C2 |
SERINE PROTEASE INHIBITORS | 1997 |
|
RU2178419C2 |
STEROID COMPOUND, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2182153C2 |
DERIVATIVES OF IMIDAZO-[1,5-A]-PYRIDINE AS INHIBITORS OF SERINE PROTEASES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2175327C2 |
STEROID WITH 17-SPIROMETHYLENELACTONE GROUP AND METHOD OF ITS SYNTHESIS | 1995 |
|
RU2168516C2 |
DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152952C2 |
Authors
Dates
2003-02-20—Published
1998-02-26—Filed